Industry: Biotechnology
Founded: 2013
Headquarters: Malvern, Pennsylvania
Website: https://www.ocugen.com
Employees: 95
IPO: December 3, 2014
Ticker: OCGN
September 30, 2019: Ocugen (OCGN) completed a reverse merger with Histogenics (Nasdaq: HSGX), creating a company focused on developing therapies for ocular diseases, operating under the Ocugen name.
No comments:
Post a Comment